Почетна › Висок крвни притисак › Тексас
Kliničke studije za Висок крвни притисак u državi Тексас
28 studija za Висок крвни притисак traži učesnike na lokacijama u državi Тексас.
Gradovi u državi Тексас
- Dallas15 студија
- Houston11 студија
- San Antonio7 студија
- Austin6 студија
- The Woodlands5 студија
- Arlington4 студија
- El Paso3 студија
- Fort Worth3 студија
Zvanični tekst studije (na engleskom)
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Allen
- Clinical Trial Site, Amarillo
- Clinical Trial Site, Amarillo
- и још 41
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07181109EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Pinnacle Clinical Research - Austin, Austin
- South Texas Research Institute - Brownsville, Brownsville
- Headlands Research - Brownsville, Brownsville
- и још 25
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07064473A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Arlington
- Research Site, Austin
- Research Site, Austin
- и још 7
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT06742723A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- IMA Clinical Research Austin, Austin
- Headlands Horizons, LLC dba Headlands Research-Brownsville, Brownsville
- Cedar Health Research - Texas Native Health, Dallas
- и још 10
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07794579A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- Retension Clinical Site, Bellaire
- Retension Clinical Site, Dallas
- Retension Clincal Site, Plano
- и још 2
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT07142356A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Horizon Clinical Research Group, Cypress
- Cardiovascular Specialists of Willowbrook, Houston
- Texas Cardiology Associates of Houston, Kingwood
- и још 2
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome
- Texas Valley Clinical Research, Weslaco
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07247162Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
- UT Southwestern Medical Center, Dallas
- William P. Clements Jr. University Hospital, Dallas
- University of Texas Health Science Center San Antonio, San Antonio
Тражи се учесникОпсервациона студија
Узраст од 18 до 100 · Оба пола · Ажурирано 30. 10. 2026. · NCT06402968SPYRAL GEMINI Pilot Study
- Baylor Heart & Vascular Hospital, Dallas
- UT Health East Texas, Tyler
Тражи се учесник
Узраст од 18 до 80 · Оба пола · Ажурирано 20. 10. 2026. · NCT06907147Global Paradise System US Post Approval Study
- Ascension Seton, Austin
- Dallas VAMC, Dallas
- TCR Institute, Kingwood
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT06297291Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
- Laguna Clinical Research Associates, Laredo
- Tapia Internal Medicine Clinic, Paris
- Baylor Scott and White Research Institute - Temple, Temple
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT07511361Reducing Cardiovascular Risks: The Role of Alcohol Use
- Science and Engineering Innovation and Research Building (SEIR), University of Texas at Arlington, Arlington
Тражи се учесник
Узраст од 26 до 49 · Оба пола · Ажурирано 6. 10. 2026. · NCT07783061BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- Baylor Scott & White Research Institute, Dallas
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT06059638THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- Plaza Medical Center of Fort Worth, Fort Worth
- Houston Medical Center, Houston
Тражи се учесник
Узраст од 22 до 75 · Оба пола · Ажурирано 24. 9. 2026. · NCT06559891Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
- University of Texas Southwestern Medical Center, Dallas
Тражи се учесникРана фаза 1Здраве особе су добродошле
Узраст од 18 до 55 · Оба пола · Ажурирано 3. 9. 2026. · NCT04838678IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
- Parkland Hospital, Dallas
Тражи се учесникЗдраве особе су добродошле
Узраст 18 и старији · Жене · Ажурирано 2. 9. 2026. · NCT06218355Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Dell Children's Medical Center of Central Texas, Austin
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 0 до 20 · Оба пола · Ажурирано 21. 8. 2026. · NCT04278404Polypill for Prevention of Cardiomyopathy
- UT Southwestern Medical Center, Dallas
Тражи се учесникФаза 1/2
Узраст од 18 до 100 · Оба пола · Ажурирано 4. 8. 2026. · NCT06143566An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Sun Research Institute, San Antonio
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 30. 7. 2026. · NCT07543120A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Synergy Group Medical LLC, Houston
- Synergy Group Medical LLC, Houston
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 30. 7. 2026. · NCT07610278A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects
- Zenos Clinical Research, Dallas
- Aavon Clinical Trials, Houston
Тражи се учесник
Узраст 22 и старији · Оба пола · Ажурирано 24. 7. 2026. · NCT06843577Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
- University of Texas Medical Branch, Galveston
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 18. 5. 2026. · NCT05955339The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.
- 3100 Cleburne Street, Nabrit Science Building,, Houston
Тражи се учесник
Узраст 55 и старији · Оба пола · Ажурирано 13. 4. 2026. · NCT07413159PRESSURE CHECK: Find Your Path to Better Health
- Houston Methodist, Houston
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 24. 3. 2026. · NCT06122246Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Carrollton
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 27. 2. 2026. · NCT07090161Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
- UT Southwestern Medical Center, Dallas
Тражи се учесник
Узраст од 18 до 60 · Оба пола · Ажурирано 10. 2. 2026. · NCT05168605Preventing Cognitive Decline by Reducing BP Target Trial
- UT Southwestern Medical Center, Dallas
Тражи се учесник
Узраст 70 и старији · Оба пола · Ажурирано 3. 12. 2025. · NCT05106036Targeting Endoplasmic Reticulum Stress in Human Hypertension
- University of North Texas Health Science Center, Fort Worth
Тражи се учесникФаза 1/2
Узраст од 18 до 80 · Оба пола · Ажурирано 28. 3. 2025. · NCT06025630Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.